Abstract
The current report focuses on purification, structural and functional characterization of Cerastategrin from Cerastes cerastes venom, a novel basic disintegrin (pI 8.36) with 128 amino acid residues and a molecular weight of 13 835.25 Da measured by MALDI-MSMS. The 3D structure of Cerastategrin is organized as α-helix (13%), β-strand (15%) and disordered structure (30%) and presents homologies with several snake venom disintegrins. Structural modeling shows that Cerastategrin presents an RGD motif that connects specifically to integrin receptors. Cerastategrin exhibits the inhibition of ADP induced platelets with an IC50 of 0.88 µg/mL and shows in vivo long stable anticoagulation effect 24 h post-injection of increasing doses ranging from 0.2 to 1 mg/kg, therefore, Cerastategrin maintained irreversibly the blood incoagulable. Moreover, Cerastategrin decreases the amount of bounded αIIbβ3 and reduced significantly the quantity of externalized P-Selectin. Cerastategrin acts as a molecule targeting specifically the receptor αIIbβ3; therefore, it behaves as a potent platelet activation inhibitor. As a new peptide with promising pharmacological properties, Cerastategrin could have a potential therapeutical effect in the vascular pathologies and may be a new effective treatment approach.
Similar content being viewed by others
Abbreviations
- Cc1-PLA2 :
-
Cerastes cerastes Phospholipase A2
- CCSV-MPase:
-
Cerastes cerastes Snake venom metalloproteinase
- SDS PAGE:
-
Sodium dodecyl sulphate
- H2SO4 :
-
Sulfuric acid
- NaOH:
-
Sodium hydroxid
- TFA:
-
Trifluorophosphate acide
- ACN:
-
Acetonetrile
- TCEP:
-
Tris(2-carboxyethyl) phosphine
- IAM:
-
10 MM 2-iodoacetamide
- EDTA:
-
Ethylenediaminetetraacetic
- EGTA:
-
Aminopolycarboxylic acid
- TRAP-6:
-
Thrombin receptor activator peptide-6
References
Harrison P (2005) Platelet function analysis. Blood Rev 19(2):111–123
Rahman S, Flynn G, Aitken AYP (2000) Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin αIIbβ3:further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery. Biochem Journal 345:701–709
Rosove MH (2004) Platelet glycoprotein IIIb/IIIa inhibitors. Best Pract Res Clin Haematol 17(1):65–76
Ozverel CS, Damm M, Hempel BF, Göçmen B, Sroka R, Süssmuth RD, Nalbantsoy A (2019) Investigating the cytotoxic effects of the venom proteome of two species of the Viperidae family (Cerastes cerastes and Cryptelytrops purpureomaculatus) from various habitats. Comp Biochem Physiol Part C 220(2018):20–30
Calvete JJ, Sanz L, Angulo Y, Lomonte B, Gutiérrez JM (2009) Venoms, venomics, antivenomics. FEBS Lett 583(11):1736–1743
Fahmi L, Makran B, Pla D, Sanz L, Oukkache N, Lkhider M, Harrison RA, Ghalim N, Calvete JJ (2012) Venomics and antivenomics profiles of North African Cerastes cerastes and C vipera populations reveals a potentially important therapeutic weakness. J Proteomics 75(8):2442–2453
Djebari FL, Martin-Eauclaire MF (1990) Purification and characterization of a phospholipase A2 from Cerastes cerastes (horn viper) snake venom. Toxicon 28(6):637–646
Matsui T, Fujimura Y, Titani K (2000) Snake venom proteases affecting hemostasis and thrombosis. Biochim Biophy. Acta 1477(1–2):146–156
Laraba-Djebari F, Martin-Eauclaire M, Marchot P (1992) A fibrinogen-clotting serine proteinase from Cerastes cerastes (horned viper) venom with arginine-esterase and amidase activities. Purification, characterization and kinetic parameter determination. Toxicon 30:1399–1410
Kang TS, Georgieva D, Genov N, Murakami MT, Sinha M, Kumar RP, Kaur P, Kumar S, Dey S, Sharma S, Vrielink A, Betzel C, Takeda S, Arni RK, Singh TP, Kini RM (2011) Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis. FEBS J 278(23):4544–4576
Rivas-Mercado E (2017) Disintegrins obtained from snake venom and their pharmacological potential. Med Univ 19:32–37
Allane D, Oussedik-Oumehdi H, Harrat Z, Seve M, Laraba-Djebari F (2018) Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom. J Biochem Mol Toxicol 32(2):1–11
Fatah C, Samah S, Laraba-Djebari F (2018) (2018) Elucidation of function mechanism of a C type lectin purified from Cerastes cerastes venom: Input of in silico and in vitro approaches. Toxicon 149:106
Juares P, Wagstaff SC, Oliver J, Sanz L, Harrison RA, Calvete JJ, Jua P (2006) Molecular cloning of disintegrin-like transcript BA-5A from a Bitis arietans venom Gland cDNA library : a putative intermediate in the evolution of the long-chain disintegrin bitistatin. J Mol Evol 63:142–152
Okuda D, Koike H, Morita T (2002) A new gene structure of the disintegrin family : a subunit of dimeric disintegrin has a short coding region. Biochemistry 41:14248–14254
Marcinkiewicz C (2005) Functional characteristic of snake venom disintegrins: potential therapeutic implication. Curr Pharm Des 11(7):815–827
Matias MS, de Oliveira F, da Cunha Pereira DF, de Queiroz MR, de Morais NCG, Mamede CCN, de Oliveira Costa J, de Sousa BB (2017) The role of platelets in hemostasis and the effects of snake venom toxins on platelet function. Toxicon 133:33–47
Ramos OHP, Selistre-De-Araujo HS (2006) Snake venom metalloproteases - Structure and function of catalytic and disintegrin domains. Comp Biochem Physiol 142(3–4):328–346
Huang T-F, Sheu J-R, Teng C-M (1991) Mechanism of Action of a Potent Antiplatelet Peptide, Triflavin from Trimeresurus flavoviridis Snake Venom. Thromb Haemost 66(04):489–493
Sheu JR, Lin CH, Peng HC, Huang TF (1996) Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Exp Biol Med 213(1):71–79
Calvete JJ, Moreno-Murciano MP, Theakston RDG, Kisiel DG, Marcinkiewicz C (2003) Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem. J 372:725–734
Samah S, Fatah C, Jean-Marc B, Safia KT, Fatima LD (2017) Purification and characterization of Cc-Lec, C-type lactose-binding lectin: a platelet aggregation and blood-clotting inhibitor from Cerastes cerastes venom. Int J Biol Macromol 102:336–350
Wu X, Koiwa H (2012) One-step casting of Laemmli discontinued sodium dodecyl sulfate–polyacrylamide gel electrophoresis gel. Anal Biochem 421(1):347–349
Van der Walt SJ, Joubert FJ (1971) Studies on puff adder (Bitis arietans) venom—I. Purification and properties of protease A. Toxicon 9:153–161
Sales PBV, Santoro ML (2008) Nucleotidase and DNase activities in Brazilian snake venoms. Comp Biochem Physiol Part 147:85–95
Chérifi F, Laraba-Djebari F (2013) Isolated biomolecules of pharmacological interest in hemostasis from Cerastes cerastes venom. J Venom Anim 19:11
Fatah C, Samah S, Fatima L (2018) Antiplatelet and anticoagulant activities of two phospholipase A2s purified from Cerastes cerastes venom: Structure-function relationship. J Biochem Mol Toxicol 32(12):e22219
Tsoupras A, Zabetakis I, Lordan R (2019) Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function in vitro. MethodsX 6:63–70
Fratantoni J, Poindexter BJ (1990) Measuring platelet aggregation with microplate reader: a new technical approach to platelet aggregation studies. Am J Clin 94:613–617
Chang H, Yanachkov I, Michelson A, Li YF (2010) Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. Thromb Journal 125:159–165
Harder S, Klinkhardt U, Graff J, Westrup D, Kirchmaier CM, Glusa E, Mascelli MA, Marciniak SJ, Just A, Lösche W, Breddin HK (2001) In vitro dose response to different GPIIb/IIIa-antagonists: Inter-laboratory comparison of various platelet function tests. Thromb Res 102(1):39–48
Kleiman NS (1999) Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors. Am Heart J 138:4
Gadhwal M, Patil S, Sci PD (2013) Homology modeling of aryl hydrocarbon receptor and docking of agonists and antagonists. Int J Pharm Pharm 5(2):76–81
Rost B (1999) Twilight zone of protein sequence alignments. Protein Eng 12(2):85–94
Li J, Abel R, Zhu K, Cao Y, Zhao S, Friesner RA (2011) The VSGB 20 model: a next generation energy model for high resolution protein structure modeling. Proteins Struct Funct Bioinforma 79(10):2794–2812
Fatah C, Saoud S, Laraba-Djebari F (2018) Pharmacological properties of a thrombin-like, inducer of platelet aggregation, purif signa ied from Cerastes cerastes venom: elucidation of activated pathway ling. Toxicol Lett 295:S105–S105
Saoud S, Chérifi F, Benhassine T, Laraba-Djebari F (2017) Purification and characterization of a platelet aggregation inhibitor and anticoagulant Cc 5_NTase, CD 73-like, from Cerastes cerastes venom. J Biochem Mol Toxicol 31(5):e21885
Chérifi F, Rousselle JC, Namane A, Laraba-Djebari F (2010) CCSV-MPase, a novel procoagulant metalloproteinase from Cerastes cerastes venom: purification, biochemical characterization and protein identification. Protein J 29(7):466–474
Kallech-Ziri O, Luis J, El Ayeb M, Marrakchi N (2007) Snake venom disintegrins: classification and therapeutic potential. Arch Inst Pasteur Tunis 84(1–4):29–37
Luis J, Ayeb ME, Marrakchi ETN (1990) Les desintegrines issues des venins de serpents : classification et potentiel therapeutique. Arch Inst Pasteur Tunis 84:29–37
Liu JW, Du XY, Liu P, Chen X, Xu JM, Wu XF, Zhou YC (2000) Purification, characterization, and cDNA sequence of halysetin, a disintegrin-like/cysteine-rich protein from the venom of Agkistrodon halys Pallas. Biochem Biophys Res Commun 278(1):112–118
Yeh CH, Peng HC, Yih JB, Huang TF (1998) A new short chain RGD-containing disintegrin, accutin, inhibits the common pathway of human platelet aggregation. Biochim Biophys Acta 1425(3):493–504
Oyama E, Takahashi H, Ishii K (2017) Effect of amino acids near the RGD sequence on binding activities between αIIbβ3 integrin and fibrinogen in the presence of RGD-containing synthetic peptides from elegantin and angustatin. Peptides 96(March):31–37
Kini RM, Evans HJ (1992) Structural domains in venom proteins: Evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30(3):265–293
Olfa KZ, José L, Salma D, Amine B, Najet SA, Nicolas A, Maxime L, Raoudha Z, Kamel M, Jacques M, Jean-Marc S, Mohamed EA, Naziha M (2005) Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis. Lab Investig 85(12):1507–1516
Gould RJ, Polokoff MA, Friedman PA, Huang T, Holt JC, Cook JJ, Niewiarowski S (1990) Disintegrins : a family of lntegrin inhibitory. Exp Biol Med 195:3–6
Oyama E, Furudate N, Senuki K, Takahashi H (2009) Purification and characterization of a new platelet aggregation inhibitor with dissociative effect on ADP-induced platelet aggregation, from the venom of Protobothrops elegans (Sakishima-habu). Toxicon 53(7–8):706–712
Calvete JJ, Jurgens M, Marcinkiewicz C, Romero A, Schrader M, Niewiarowski S (2000) Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom. Biochem J 345(Pt 3):573–581
Bilgrami S, Tomar S, Yadav S, Kaur P, Kumar J, Jabeen T, Sharma S, Singh TP (2004) Crystal structure of schistatin, a disintegrin homodimer from saw-scaled viper (Echis carinatus) at 25 Å resolution. J Mol Biol 341(3):829–837
Calvete JJ, Wang Y, Mann K, Schäfer W, Niewiarowski S, Stewart GJ (1992) The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett 309(3):316–320
Hantgan RR, Stahle MC, Connor JH, Lyles DS, Horita DA, Rocco M, Nagaswami C, Weisel JW, McLane MA (2004) The disintegrin echistatin stabilizes integrin αIIbβ3’s open conformation and promotes its oligomerization. J Mol Biol 342(5):1625–1636
McLane MA, Vijay-Kumar S, Marcinkiewicz C, Calvete JJ, Niewiarowski S (1996) Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of αIIbβ3 and αvβ3 integrins. FEBS Lett 391(1–2):139–143
Moreno-Murciano MP, Monleón D (2003) NMR solution structure of the non-RGD disintegrin obtustatin. J Mol Biol 329:135–145
Beviglia L, Poggi A, Rossi C, McLane MA, Calabrese R, Scanziani E, Cook JJ, Niewiarowski S (1993) Mouse antithrombotic assay: inhibition of platelet thromboembolism by disintegrins. Thromb Res 71(4):301–315
Shebuski RJ, Ramjit DR, Bencen GH, Polokoff MA (1989) Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper bitis arietans. J Biol Chem 264(36):21550–21556
Hall EH, Slack RJ (2018) (2019) The effect of divalent metal cations on the αv integrin binding site is ligand and integrin specific. Biomed Pharmacother 110:362–370
Xiong JP, Stehle T, Goodman SL, Arnaout MA (2003) Integrins, cations and ligands: making the connection. J Thromb Haemost 1(7):1642–1654
Kühnel G, Pralle H, Matzdorff AC, Kemkes-Matthes B, Voss R, Fareed J (2003) Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro. J Lab Clin Med 135(3):247–255
Scazziota A, Altman R, Rouvier J, Gonzalez C, Ahmed Z, Jeske WP, Walenga JM, Fareed J (2000) Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression. Thromb Res 100(6):479–488
Swaim MW, Chiang HS, Huang TF (1996) Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides Trigramin and Rhodostomin. Eur J Cancer 32(4):715–721
Liu CZ, Peng HC, Huang TF (1995) Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis. Toxicon 33(10):1289–1298
Knight LC, Romano JE (2005) Functional expression of bitistatin, a disintegrin with potential use in molecular imaging of thromboembolic disease. Protein Expr Purif 39(2):307–319
Trikha M, Rote WE, Manley PJ, Lucchesi BR, Markland FS (1994) Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb Res 73(1):39–52
Lazarus RA, McDowell RS (1993) Structural and functional aspects of RGD-containing protein antagonists of glycoprotein IIb-IIIa. Curr Opin Biotechnol 4(4):438–445
Mion G, Olive F, Hernandez E, Martin YN, Vieillefosse AS, Goyffon M (2002) Action des venins sur la coagulation sanguine : diagnostic des syndromes hémorragiques. Bull Soc Pathol Exot 95(3):132–132
Juárez P, Comas I, González-Candelas F, Calvete JJ (2008) Evolution of snake venom disintegrins by positive Darwinian selection. Mol Biol Evol 25(11):2391–2407
Rucinski B, Niewiarowski S, Holt JC, Soszka T, Knudsen KA (1990) Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. BBA 1054(3):257–262
Sohn Y, Hong S, Cho K, Choi W (2008) Acute and repeated dose toxicity studies of recombinant saxatilin, a disintegrin from the Korean snake (Gloydius saxatilis). Toxicon 51:406–417
Wermelinger LS, Geraldo RB, Frattani FS, Rodrigues CR, Juliano MA, Castro HC, Zingali RB (2009) Integrin inhibitors from snake venom: Exploring the relationship between the structure and activity of RGD-peptides. Arch Biochem Biophys 482(1–2):25–32
Acknowledgements
The authors want to acknowledge Dr Hocine Rachid from INSERM UMRS 976 and University of Paris-Diderot, Saint Louis Hospital, Paris 75010, France for his help in purity control.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflict of interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ameziani, M., Chérifi, F., Kiheli, H. et al. Isolation and Functional Identification of an Antiplatelet RGD-Containing Disintegrin from Cerastes cerastes Venom. Protein J 39, 574–590 (2020). https://doi.org/10.1007/s10930-020-09915-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-020-09915-y